logo
Men Mention AI Skills 2x More Than Women — What 31,000 Resumes Reveal

Men Mention AI Skills 2x More Than Women — What 31,000 Resumes Reveal

Our analysis of 31,000 resumes reveals key hiring trends—AI skill gaps, resume length shifts, rising video resumes, and growing concerns over AI bias.
'Men mention AI skills 2x more than women, widening the tech gap. AI hiring tools also favor white names 85% of the time—if unchecked, bias in hiring could scale instead of shrink.' — Volen Vulkov, CEO Enhancv
NEW YORK, NY, UNITED STATES, March 17, 2025 / EINPresswire.com / -- Americans Are Rewriting the Rules of Resumes — New Report Reveals How
The resume is evolving, and so are job seekers' strategies to stand out. A new report from Enhancv, analyzing over 31,000 resumes, highlights a shift in hiring trends—challenging long-held norms and reshaping the modern job search.
Кey findings: These are just a few highlights—our full report includes over 200 data insights on how job seekers and recruiters are adapting to the changing job market.
1. Gender Gap in AI Adoption – Men mention AI skills 2x more than women, widening the tech representation gap.
2. Resumes Are Getting Longer – The once-standard one-page rule is fading as the average resume now stretches to 1.7 pages.
3. More Skills, More Problems? – Job seekers are packing resumes with over 11 skills on average, but hiring managers emphasize quality over quantity.
4. Resumes Are Getting Longer – Two-page resumes are now the norm, with 47% of job seekers using them—62% longer than one-pagers. Remote workers are most likely to exceed one page.
5. The AI Resume Boom – AI is playing a bigger role in hiring, but 83% of companies still prioritize personalized applications over AI-generated resumes.
6. AI Bias in Hiring – AI favors white-associated names 85% of the time, raising concerns about fairness as automation becomes more common.
7. TikTok Resumes on the Rise – 61% of job seekers see video resumes as the future, while 79% of hiring managers already use video to evaluate candidates.
8. Freelancing Boom – 36% of the U.S. workforce freelanced in 2024, with freelancers averaging 15 years of experience, outpacing traditional roles.
What does this mean for job seekers?
The hiring landscape is evolving fast, and outdated resume strategies could mean missed opportunities. With AI integration, new resume formats, and shifting recruiter preferences, job seekers must adapt to stay competitive.
About Enhancv
Enhancv helps job seekers get hired at top companies by offering expert career advice, AI resume tools, and professional templates designed to beat ATS screening and get interview callbacks.
Volen Valkov
Legal Disclaimer:
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Veteran trader posts a major warning for the stock market
Veteran trader posts a major warning for the stock market

Miami Herald

time7 minutes ago

  • Miami Herald

Veteran trader posts a major warning for the stock market

Human beings and fear go back a long way. It's an ancient survival mechanism, passed down through the generations, as our cave-dwelling ancestors contended with wild animals, natural disasters and each other. Don't miss the move: Subscribe to TheStreet's free daily newsletter The right kind of fear can keep you alive, but the wrong kind can keep you from making a move. "It's only natural," said TheStreet Pro's Stephen Guilfoyle. "Fear of the dark. Fear of the unknown. Fear of the known. You still do what you have to." Guilfoyle, whose trading career dates back to the floor of the New York Stock Exchange of the 1980s, in a recent column considered a certain kind of fear - where you're moving through an unfamiliar environment and you get a feeling you may have company. "Maybe a big cat or something predatory might be tracking you," he said. "That realization always makes the hairs on the back of my neck stand up. I call that the 'nasties.'"The stock market can be a source of the nasties when the numbers start heading into the red, as they have been lately. And it's not the big cats you have to worry about in this jungle. It's the bears. More Experts Stocks and Markets Podcast: Prairie Operating CEO on energy businessDave Ramsey warns Americans on Social SecurityLegendary fund manager reveals new trades after S&P 500 rally Stocks were tumbling at last check on Aug. 1 on signs of a weakening economy. The Bureau of Labor Statistics said that just 73,000 jobs were created in July, causing the unemployment rate to tick up to 4.2% from 4.1% in June. President Donald Trump promptly fired BLS Commissioner Erika McEntarfer, accusing her being a political appointee who was manipulating jobs data, CNBC reported. "We need accurate Jobs Numbers. I have directed my Team to fire this Biden Political Appointee, IMMEDIATELY," Trump said on his Truth Social platform. "She will be replaced with someone much more competent and qualified." Trump also took another shot at the Federal Reserve chairman, saying that "Jerome 'Too Late' Powell should also be put 'out to pasture.'" Guilfoyle noted that things went bad on July 31 half an hour after the opening bell and "got uglier around lunchtime and uglier still going into the final hour of play." While Meta Platforms (META) and Microsoft (MSFT) rallied, Guilfoyle noted that the "joy" was put to the test early as the Bureau of Economic Analysis posted its July data for personal income and outlays as well as July consumer-level inflation. "Just a day after the quarterly data for inflation had put traders and investors at ease, the monthly data did just the opposite," he said. "Like a jaguar in the shadows, hard to see, watching from just far enough to raise those hairs on the back of your neck." He said Trump "put the whammy on 'big pharma,' sending letters to 17 leading drugmakers and demanding that these firms take steps to lower prices in the U.S. They have 60 days to get on board with his "most favored nation drug policy." Trump also signed an executive order revising tariffs on many nations that had failed to reach new trade deals with the U.S. Related: Warren Buffett sends White House blunt message on the economy "One must remember that while it may not look that ugly at the major index level, the selling was nearly constant on Thursday and markets sold off from an upward burst early on," Guilfoyle said. Eight of the 11 S&P sector SPDR ETFs closed in the red on July 31, and Guilfoyle, known on Wall Street as Sarge, called upon his military experience to explain what happens next. "So, this is where we realize that we may be up against something," he said. "This is where you stop moving, get low, unsnap your Ka-bar and switch your weapon off of 'safe.'" (The Ka-bar is a combat knife.) Losers beat winners by almost 3 to 2 on the New York Stock Exchange and by almost 2 to 1 on the Nasdaq, Guilfoyle said Advancing volume took just a 32.9% share of composite NYSE-listed trade and a 36.1% share of Nasdaq-listed trade, he added. More important, "aggregate trading volume increased across the listings at both the NYSE and Nasdaq as well as across the membership of the S&P 500." "Gang, you know what that means, right?" he asked. "Thursday qualifies as a potential 'Day One' bearish reversal." He said that a large selloff on Aug. 1 would be seen as a continuation of Day 1 and that "we actually need to see a break or pause in between any Day 1 and any Day of Confirmation." (FYI: The S&P 500 finished Aug. 1 down 1.6%.) "Can anything help? Can anything make it worse?" he asked. "The algorithms that control the point of sale stand ready to overreact, force momentum overshoot and create market inefficiency." "You know that as this is what they are designed to do, so keep your helmet on and buckle your chinstrap," Guilfoyle added. Related: Veteran fund manager who forecast S&P 500 crash unveils surprising update The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

OPEC+ Countries Agree to Boost Oil Production: What to Know
OPEC+ Countries Agree to Boost Oil Production: What to Know

Newsweek

time3 hours ago

  • Newsweek

OPEC+ Countries Agree to Boost Oil Production: What to Know

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Members of the Organization of Petroleum Exporting Countries (OPEC+) on Sunday announced plans to increase oil production by over half a million barrels per day for September as concerns over supply disruptions persist. The eight members of OPEC+ held a virtual meeting in response to U.S. pressure on some nations—such as India—to halt all Russian oil purchases in an additional move aimed at pressuring Moscow to end its ongoing conflict in Ukraine. However, OPEC+ said it would increase output due to a healthy economy and low oil inventory, with oil prices remaining at a higher level even as output has increased from members. Newsweek reached out to the White House and Department of Energy (DOE) by email on Sunday outside of normal business hours for comment. Why It Matters President Donald Trump in last year's presidential campaign promised to tackle a number of major targets, including an end to the Russia-Ukraine war and lowering prices for Americans amid high inflation. Russian President Vladimir Putin's resistance to diplomatic efforts has frustrated Trump and forced the U.S. to seek more creative means to try and achieve an end to the war that began in February 2022. What To Know The U.S. has looked at imposing tariffs on Russia and convincing countries that still purchase Russian oil to switch to other sources. Some feared that these actions could drive up gas prices for Americans, as well. However, those fears appear to have been averted as OPEC+ agreed to increase production, providing a healthy alternative to Russian oil. OPEC+ includes Saudi Arabia, Russia, Iraq, United Arab Emirates, Kuwait, Kazakhstan, Algeria and Oman. It remains unclear how this could impact Russia's other sales and negotiations. OPEC+ has made voluntary production cuts since November 2023, with plans to phase those cuts out by September 2026, but the announcement means that the countries will increase output for the second time this year—following July's announcement of a similar increase in August—and effectively ending the program early. Prices have remained at the higher rate of around $70 a barrel for Brent crude despite the increased output, however, raising some doubts as to what impact the increased output might have on gas prices. An Austrian soldier stands outside of the building headquarters of OPEC (Organization of The Petroleum Exporting Countries) in Vienna, Austria on May 28. An Austrian soldier stands outside of the building headquarters of OPEC (Organization of The Petroleum Exporting Countries) in Vienna, Austria on May 28. Joe Klamar/AFP via Getty Images What People Are Saying President Donald Trump last week wrote on Truth Social, in part: "We have just concluded a Deal with the Country of Pakistan, whereby Pakistan and the United States will work together on developing their massive Oil Reserves. We are in the process of choosing the Oil Company that will lead this Partnership. Who knows, maybe they'll be selling Oil to India some day!" Mark Temnycky, a nonresident fellow at the Atlantic Council think tank's Eurasia Center, previously told Newsweek: "If the U.S. follows with new restrictions or tariffs, Americans could see higher energy prices, especially at the gas pump and in sectors tied closely to fuel, like transportation and manufacturing." He added: "These cost increases may filter down to everyday goods as companies adjust for rising input expenses. In addition, inflation will be a concern for many American consumers and policymakers." What Happens Next? The members will meet again in September for further discussions and adjustments to production. This article includes reporting by the Associated Press.

Beyond Trump's trade deals, consolation for the little guy and other commentary
Beyond Trump's trade deals, consolation for the little guy and other commentary

New York Post

time4 hours ago

  • New York Post

Beyond Trump's trade deals, consolation for the little guy and other commentary

Business desk: Beyond Trump's Trade Deals 'Dealmaker-In-Chief' Donald Trump has been 'positively monomaniacal' about trade lately, marvels Freddy Gray at The Spectator. His 'real coup' is the 'new framework arrangement with the European Union,' which is 'not simply a major breakthrough in and of itself,' but also 'a useful piece of leverage in the even bigger tariff struggle with China' — because it pulls 'Europe more towards a western trading orbit and less towards the east.' Trump then slammed India for 'buying up Russian oil and gas,' and pivoted sharply by praising a new deal with Pakistan, 'including an arrangement to invest in Pakistani oil.' Advertisement Meanwhile, his enthusiasm for Pakistan — 'an extension of China's empire' — may be part of a plan to 'ring loud alarm bells' in Beijing. From the right: Consolation for the Little Guy 'For all the political criticism they take, the federal courts keep delivering good outcomes more often than not,' cheers The Wall Street Journal's Editorial Board. In 2016, the Labor Department 'imposed hundreds of thousands of dollars in fines' on a fourth-generation farm, Sun Valley Orchards — first requesting penalties and then approving them itself, thus 'serving as prosecutor, judge and jury.' Advertisement But an appeals court just ruled the proceedings 'should properly be enforced in federal court' — the proper venues for federal agencies to impose fines. Sun Valley has since gone out of business,' but at least its owners 'have the consolation of a ruling that will vindicate the rights of other farmers and small businesses under the boot heel of the bureaucracy.' Libertarian: Get Honest About Gov't Spending 'What kind of government do Americans want seriously enough to pay for?' asks Veronique de Rugy at Reason. 'I suspect that most people aren't willing to pay the taxes required to fund everything our current government does.' Advertisement Yet 'all the benefits and subsidies that we're unwilling to pay for' but keep going 'will eventually have to be paid for in the future with higher taxes, inflation, or both' by our children and grandchildren. 'Growing the economy' can be 'part of the solution,' but it won't be enough, and 'raising taxes on the rich will fall short too,' since higher tax rates 'do not automatically translate to more tax revenue.' 'It's long past time' we 'ask what level of spending we truly want with the money we truly have.' Get opinions and commentary from our columnists Subscribe to our daily Post Opinion newsletter! Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters Liberal: Hey, Dems — End the #Resistance Advertisement 'Nonstop Democratic fulminations in Trump's second term have been notably unsuccessful in resuscitating the party's toxic brand,' sighs the Liberal Patriot's Ruy Teixeira. Tellingly, 'voters, despite their negative views of Trump's performance on key issues, still prefer Republicans to Democrats.' Also, 'voters neither like nor trust' Dems, and thus don't see them as 'an obvious choice over their opponents.' Yet 'many Democratic politicians persist in reading — loudly — from the #Resistance script.' Why? The '#Resistance trope is what advantages individual Democratic politicians within the party because it generates adulation from activists, media coverage, and gushers of donations.' And taking back the House in 2026 will only 'convince #Resistance aficionados that nothing really needs to change.' Hello, President JD Vance. Health beat: Big Pharma Wins, Patients Lose 'In May, Dr. Vinay Prasad joined the Food & Drug Administration as the top regulator for vaccines,' yet he 'apparently knew the games too well,' gripes Alex Berensen at his Substack: After last week's attacks from Trump's allies, Prasad resigned: 'He was targeted because he posed a direct threat to Big Pharma profits.' Advertisement Just last month, he told Sarepta Therapeutics 'it needed to halt shipments of its gene therapy for Duchenne muscular dystrophy, or DMD.' 'Sarepta has never shown its drugs actually benefit patients.' The company won the right to a drug trial in 2016; 'nine years later, Sarepta still hasn't completed those trials.' Yet 'that hasn't stopped it from selling the drug — for up to $1.5 million per year.' Advertisement 'Big Pharma scalped Prasad for his honesty.' — Compiled by The Post Editorial Board

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store